Skip to content

Platform
- Overview
- Publications
Pipeline
About
Investors
Careers
Contact

Platform
- Overview
- Publications
Pipeline
About
Investors
Careers
Contact

Platform:
Publications

man working - Alto publications hero

Leveraging clinical and biological insights to drive innovation in psychiatry

See our publications, presentations, and more to discover the revolutionary potential of our precision approach.

Choose Resource Type
Choose Focus Area
Search Resources

Found 56 Results

September 1, 2024

Prevalence and Correlates of Cognitive Impairment in Depression: Findings from the Texas Resilience Against Depression Study

September 1, 2024

A Biomarker-Based Enrichment Strategy for Neuropsychiatric Drug Development: Examples from Two Ongoing Phase 2b Studies

September 1, 2024

Identification of Brain/Behavior-based Pro-cognitive Pharmacodynamic Effects for ALTO-101 in Healthy Volunteers: Results from a Randomized, Double-blind Phase 1 Study and a PK/Tolerability Phase 1 Study

August 21, 2024

Opportunities for use of neuroimaging in de-risking drug development and improving clinical outcomes in psychiatry: an industry perspective

May 1, 2024

Verbal Memory and Inhibitory Control Predict Functional Capacity and Impairment in Major Depressive Disorder: A Secondary Analysis of the ReMIND SWITCH Trial

May 1, 2024

Identification and Prospective Replication of Electrophysiological Markers Linked to Cognitive Impairment in Schizophrenia (CIAS)

May 1, 2024

Baseline Cognition is Not Associated with Depression Outcomes with Vortioxetine for Major Depressive Disorder: Findings from Placebo-Controlled Trials

«1 234 5...»

650 Castro Street, Suite 450
Mountain View, CA 94041

Company

About
Leadership
Careers
Contact

Science

Platform
Publications
Pipeline

Investors

Overview
News
Events & Presentations
Stock Info
SEC Filings
Corporate Governance
Resources

Privacy Policy
Terms of Use
Accessibility
Cookie Policy

© 2025 Alto Neuroscience Inc. All rights reserved.

Scroll to Top